Evidence map›Paper›PMID 26923586›Full record

ArticleCell reports2016

IL-7 Induces SAMHD1 Phosphorylation in CD4+ T Lymphocytes, Improving Early Steps of HIV-1 Life Cycle.

Mayte Coiras, Mercedes Bermejo, Benjamin Descours, Elena Mateos, Javier García-Pérez, María-Rosa López-Huertas, Michael M Lederman, Monsef Benkirane, José Alcamí

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Mayte CoirasAIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid 28220, Spain. Electronic address: mcoiras@isciii.es.
Mercedes BermejoAIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid 28220, Spain.
Benjamin DescoursInstitut de Génétique Humaine CNRS UPR1142, Université de Montpellier, Laboratoire de Virologie Moléculaire, Montpellier 34000, France.
Elena MateosAIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid 28220, Spain.
Javier García-PérezAIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid 28220, Spain.
María-Rosa López-HuertasAIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid 28220, Spain.
Michael M LedermanCase Western Reserve University, University Hospitals Case Medical Center, Cleveland, OH 44106, USA.
Monsef BenkiraneInstitut de Génétique Humaine CNRS UPR1142, Université de Montpellier, Laboratoire de Virologie Moléculaire, Montpellier 34000, France.
José AlcamíAIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid 28220, Spain. Electronic address: ppalcami@isciii.es.
Escuela Nacional de Sanidad · ESInstituto de Salud Carlos III · ESCase Western Reserve University · USCentre National de la Recherche Scientifique · FRInstitut de Génétique Moléculaire de Montpellier · FR

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
Case Clinical Trials Unit: Administrative Supplement NOSI AI-20-031.UM1AI069501 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI George Yendewa · 2012 to 2026
$40.4M
Case AIDS Clinical Trials UnitU01AI069501 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL · 2007 to 2011
$14.7M
NIAID NIH HHS AI 069501NIAID NIH HHS P30 AI036219NIAID NIH HHS U01 AI069501NIAID NIH HHS UM1 AI069501
6 · The paper itself

Abstract

HIV-1 post-integration latency in CD4+ lymphocytes is responsible for viral persistence despite treatment, but mechanisms involved in the establishment of latent viral reservoirs are not fully understood. We determined that both interleukin 2 (IL-2) and IL-7 induced SAMHD1 phosphorylation in T592, abrogating its antiviral activity. However, IL-7 caused a much more profound stimulatory effect on HIV-1 reverse transcription and integration than IL-2 that required chemokine co-stimulation. Both cytokines barely induced transcription due to low NF-κB induction, favoring the establishment of latent reservoirs. Effect of IL-7 on SAMHD1 phosphorylation was confirmed in IL-7-treated patients (ACTG 5214 study). Dasatinib--a tyrosine-kinase inhibitor--blocked SAMHD1 phosphorylation induced by IL-2 and IL-7 and restored HIV-1 restriction. We propose that γc-cytokines play a major role in the reservoir establishment not only by driving homeostatic proliferation but also by increasing susceptibility of CD4+ lymphocytes to HIV-1 infection through SAMHD1 inactivation.

Indexed as

Virus IntegrationCD4-Positive T-LymphocytesCells, CulturedHIV-1HumansInterleukin-2Interleukin-7Monomeric GTP-Binding ProteinsPhosphorylationProtein Processing, Post-TranslationalReverse TranscriptionSAM Domain and HD Domain-Containing Protein 1IL7 protein, humanInterleukin-2Interleukin-7Monomeric GTP-Binding ProteinsSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, human

Identifiers

PMID26923586
PMCPMC5063304
OpenAlexW2274212151

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.